MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/jc.2003-031640

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2004

Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone.

Gaasenbeek Michelle, Powell Brenda L, Sovio Ulla, Haddad Lema, Gharani Neda, Bennett Amanda, Groves Christopher J, Rush Karen, Goh Micaela J, Conway Gerard S, Ruokonen Aimo, Martikainen Hannu, Pouta Anneli, Taponen Saara, Hartikainen Anna-Liisa, Halford Stephanie, Järvelin Marjo-Riitta, Franks Steve, McCarthy Mark I

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

CYP11A, the gene encoding p450scc, a key enzyme in steroid biosynthesis, is a strong biological candidate for polycystic ovary syndrome (PCOS) susceptibility. Four of the five published studies that have examined CYP11A for evidence of linkage and/or association have reported significant relationships with polycystic ovary (PCO) status and/or serum testosterone levels. However, study sizes have been modest, and the current study aimed to reevaluate these findings using significantly larger clinical resources. A pair of CYP11A promoter microsatellites, including the pentanucleotide (D15S520) previously implicated in trait susceptibility, were genotyped in 371 PCOS patients of United Kingdom origin, using both case-control and family-based association methods, and in 1589 women from a population-based birth cohort from Finland characterized for PCO symptomatology and testosterone levels. Although nominally significant differences in allele and genotype frequencies at both loci were observed in the United Kingdom case-control study (for example, an excess of the pentanucleotide four-repeat allele in cases, P = 0.005), these findings were not substantiated in the other analyses, and no discernable relationship was seen between variation at these loci and serum testosterone levels. These studies indicate that the strength of, and indeed the existence of, associations between CYP11A promoter variation and androgen-related phenotypes has been substantially overestimated in previous studies.

Для цитирования: Gaasenbeek Michelle, Powell Brenda L, Sovio Ulla, Haddad Lema, Gharani Neda, Bennett Amanda, Groves Christopher J, Rush Karen, Goh Micaela J, Conway Gerard S, Ruokonen Aimo, Martikainen Hannu, Pouta Anneli, Taponen Saara, Hartikainen Anna-Liisa, Halford Stephanie, Järvelin Marjo-Riitta, Franks Steve, McCarthy Mark I. Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone.. The Journal of clinical endocrinology and metabolism. 2004. DOI: 10.1210/jc.2003-031640.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.